Association of thrombotic microangiopathy and intimal hyperplasia with bleeding post-renal biopsy in antiphospholipid antibody-positive patients

Arthritis Care and Research

Volumn 66, Issue 5, 2014, Pages 725-731

  Jordan, Natasha ^a   Chaib, Ahlem ^a   Sangle, Shirish ^a   Tungekar, Fahim ^a   Sabharwal, Tarun ^a   Abbs, Ian ^a   Khamashta, Munther ^a   D'Cruz, David ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; CREATININE; HEMOGLOBIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ABDOMINAL BLEEDING; ADULT; AGE; ANGIOGRAPHY; ANTIPHOSPHOLIPID SYNDROME; ARTERY INTIMA; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CLINICAL OBSERVATION; COIL EMBOLIZATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DEATH; DISEASE ASSOCIATION; FEMALE; FIBROUS INTIMAL HYPERPLASIA; HEMATOMA; HEMATURIA; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HUMAN TISSUE; HYPERPLASIA; KIDNEY BIOPSY; KIDNEY DISEASE; LAPAROTOMY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEPHRECTOMY; PERIRENAL HEMATOMA; POST RENAL BIOPSY BLEEDING; RETROPERITONEAL HEMATOMA; RETROSPECTIVE STUDY; RISK FACTOR; SEPTICEMIA; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; FEMALE; HEMORRHAGE; HUMANS; HYPERPLASIA; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; NEPHRECTOMY; RETROSPECTIVE STUDIES; THROMBOTIC MICROANGIOPATHIES; TUNICA INTIMA; YOUNG ADULT;

EID: 84899104450     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.22200     Document Type: Article

References (33)

1. Appel GB, Cohen DJ, Pirani CL, Meltzer JI, Estes D,. Long-term follow-up of patients with lupus nephritis: a study based on the classification of the World Health Organization. Am J Med 1987; 83: 877-85. (Pubitemid 18098162)
2. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, et al, for the European Working Party on Systemic Lupus Erythematosus. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003; 82: 299-308. (Pubitemid 37229465)
3. Danila MI, Pons-Estel GJ, Zhang J, Vila LM, Reveille JD, Alarcon GS,. Renal damage is the most important predictor of mortality within the damage index: data from LUMINA LXIV, a multiethnic US cohort. Rheumatology (Oxford) 2009; 48: 542-5.
4. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol 2004; 15: 241-50. (Pubitemid 38140764)
5. Austin HA III, Boumpas DT, Vaughan EM, Balow JE,. Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int 1994; 45: 544-50. (Pubitemid 24065091)
6. Nossent HC, Henzen-Logmans SC, Vroom TM, Berden JH, Swaak TJ,. Contribution of renal biopsy data in predicting outcome in lupus nephritis: analysis of 116 patients. Arthritis Rheum 1990; 33: 970-7. (Pubitemid 20226350)
7. Esdaile JM, Federgreen W, Quintal H, Suissa S, Hayslett JP, Kashgarian M,. Predictors of one year outcome in lupus nephritis: the importance of renal biopsy. Q J Med 1991; 81: 907-18.
8. McLaughlin JR, Bombardier C, Farewell VT, Gladman DD, Urowitz MB,. Kidney biopsy in systemic lupus erythematosus. III. Survival analysis controlling for clinical and laboratory variables. Arthritis Rheum 1994; 37: 559-67.
9. Hughes GR, Harris NN, Gharavi AE,. The anticardiolipin syndrome. J Rheumatol 1986; 13: 486-9.
10. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999; 42: 1309-11. (Pubitemid 30265586)
11. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
12. Khamashta M, Hughes GR,. Antiphospholipid syndrome. BMJ 1993; 307: 883-4. (Pubitemid 23293496)
13. McNeil HP, Hunt JE, Krilis SA,. Antiphospholipid antibodies: new insights into their specificity and clinical importance. Scand J Immunol 1992; 36: 647-52.
14. Nochy D, Daugas E, Droz D, Beaufils H, Grunfeld JP, Piette JC, et al. The intrarenal vascular lesions associated with primary antiphospholipid syndrome. J Am Soc Nephrol 1999; 10: 507-18. (Pubitemid 29117632)
15. Yoshimoto M, Fujisawa S, Sudo M,. Percutaneous renal biopsy well-visualized by orthogonal ultrasound application using linear scanning. Clin Nephrol 1988; 30: 106-10.
16. Burstein DM, Schwartz MM, Korbet SM,. Percutaneous renal biopsy with the use of real-time ultrasound. Am J Nephrol 1991; 11: 195-200.
17. Doyle AJ, Gregory MC, Terreros DA,. Percutaneous native renal biopsy: comparison of a 1.2-mm spring-driven system with a traditional 2-mm hand-driven system. Am J Kidney Dis 1994; 23: 498-503. (Pubitemid 24109110)
18. Korbet SM,. Percutaneous renal biopsy. Semin Nephrol 2002; 22: 254-67. (Pubitemid 34525931)
19. Whittier WL, Korbet SM,. Timing of complications in percutaneous renal biopsy. J Am Soc Nephrol 2004; 15: 142-7. (Pubitemid 38020705)
20. Manno C, Strippoli GF, Arnesano L, Bonifati C, Campobasso N, Gesualdo L, et al. Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy. Kidney Int 2004; 66: 1570-7. (Pubitemid 39298392)
21. Stratta P, Canavese C, Marengo M, Mesiano P, Besso L, Quaglia M, et al. Risk management of renal biopsy: 1387 cases over 30 years in a single centre. Eur J Clin Invest 2007; 37: 954-63. (Pubitemid 350151186)
22. Marwah DS, Korbet SM,. Timing of complications in percutaneous renal biopsy: what is the optimal period of observation? Am J Kidney Dis 1996; 28: 47-52. (Pubitemid 26231465)
23. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997; 40: 1725.
24. Lockshin MD, Sammaritano LR, Schwartzman S,. Validation of the Sapporo criteria for antiphospholipid syndrome. Arthritis Rheum 2000; 43: 440-3. (Pubitemid 30395755)
25. Harris EN, Chan JK, Asherson RA, Aber VR, Gharavi AE, Hughes GR,. Thrombosis, recurrent fetal loss, and thrombocytopenia: predictive value of the anticardiolipin antibody test. Arch Intern Med 1986; 146: 2153-6. (Pubitemid 17189088)
26. Shidham GB, Siddiqi N, Beres JA, Logan B, Nagaraja HN, Shidham SG,. Clinical risk factors associated with bleeding after native kidney biopsy. Nephrology 2005; 10: 305-10. (Pubitemid 40910380)
27. Tang S, Li JH, Lui SL, Chan TM, Cheng IK, Lai KN,. Free-hand, ultrasound-guided percutaneous renal biopsy: experience from a single operator. Eur J Radiol 2002; 41: 65-9. (Pubitemid 34002993)
28. Eiro M, Katoh T, Watanabe T,. Risk factors for bleeding complications in percutaneous renal biopsy. Clin Exp Nephrol 2005; 9: 40-5. (Pubitemid 40576883)
29. Alarcon-Segovia D, Cardiel MH, Reyes E,. Antiphospholipid arterial vasculopathy. J Rheumatol 1989; 16: 762-7. (Pubitemid 19182960)
30. Sipek-Dolnicar A, Hojnik M, Bozic B, Vizjak A, Rozman B, Ferluga D,. Clinical presentations and vascular histopathology in autopsied patients with systemic lupus erythematosus and anticardiolipin antibodies. Clin Exp Rheumatol 2002; 20: 335-42. (Pubitemid 35012567)
31. Fraser IR, Fairley KF,. Renal biopsy as an outpatient procedure. Am J Kidney Dis 1995; 25: 876-8.
32. Waldo B, Korbet SM, Freimanis MG, Lewis EJ,. The value of post-biopsy ultrasound in predicting complications after percutaneous renal biopsy of native kidneys. Nephrol Dial Transplant 2009; 24: 2433-9.
33. Jones B, Puvaneswary M, Nanra R, Trevillian P, Carney S, Gillies A,. Reduced duration of bed rest after percutaneous renal biopsy. Clin Nephrol 1991; 35: 44-5.